|
|
Previous Article | Table of Contents | Next Article 
Blood, 1 September 2002, Vol. 100, No. 5, pp. 1869-1877
PHAGOCYTES
Essential role of the C5a receptor in E coli-induced
oxidative burst and phagocytosis revealed by a novel lepirudin-based
human whole blood model of inflammation
Tom Eirik Mollnes,
Ole-Lars Brekke,
Michael Fung,
Hilde Fure,
Dorte Christiansen,
Grethe Bergseth,
Vibeke Videm,
Knut Tore Lappegård,
Jörg Köhl, and
John D. Lambris
From the Institute of Immunology, The National
Hospital, University of Oslo, Norway; Department of Immunology and
Transfusion Medicine, Department of Clinical Chemistry, and Medical
Department, Nordland Central Hospital and University of Tromsø;
Department of Immunology and Transfusion Medicine, Institute of
Laboratory Medicine, Norwegian University of Science and Technology,
Trondheim, Norway; Institute of Medical Microbiology, Medical School,
Hannover, Germany; Tanox, Houston, TX; and Laboratory of Protein
Chemistry, Department of Pathology and Laboratory Medicine, University
of Pennsylvania, PA.
Complement plays an essential role in inflammation and tissue
damage. However, it is largely unknown to what extent the system acts
as a primary inducer of secondary mediator systems in the inflammatory
network of human whole blood. Here we describe a novel in vitro model
using the thrombin-specific hirudin analog lepirudin as anticoagulant,
which, in contrast to heparin, did not interfere with complement
activation. The model was used to study the role of complement in
Escherichia coli-induced inflammatory responses.
Granulocyte and monocyte oxidative burst was complement dependent as it
was reduced by 85% and 70%, respectively, by the CD3 binding peptide
compstatin. A similar reduction was found by inhibition of C5, C5a, and
C5a receptor (C5aR). Furthermore, anti-CR3 antibodies were as efficient
as the C5aR antagonist in reducing granulocyte oxidative burst, whereas
blocking CD14 or C3aR had no effect. Up-regulation of granulocyte CR3
was virtually abolished by a C5aR antagonist. Opsonization and
phagocytosis was completely inhibited by blocking of C5aR or CR3,
whereas blocking of the Fc Rs (CD16, CD32, CD64) had no effect. In
contrast to oxidative burst and phagocytosis, cytokine secretion was
largely complement independent. Thus, anti-CD14 abolished tumor
necrosis factor- , interleukin-6 (IL-6), and IL-10 secretion, whereas
IL-8 was equally inhibited by anti-CD14 and compstatin. In conclusion, the present model is particularly useful for studying complement as
part of the inflammatory network. The results emphasize a crucial role
for C5a-C5aR interaction in E coli-induced up-regulation of CR3 and the subsequent oxidative burst and phagocytosis. Complement inhibition may have therapeutic implications in oxidative
burst-induced tissue damage.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. B. Thorgersen, A. Pharo, K. Haverson, A. K. Axelsen, P. Gaustad, G. J. Kotwal, G. Sfyroera, and T. E. Mollnes
Inhibition of Complement and CD14 Attenuates the Escherichia coli-Induced Inflammatory Response in Porcine Whole Blood
Infect. Immun.,
February 1, 2009;
77(2):
725 - 732.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Schreiber, H. Xiao, J. C. Jennette, W. Schneider, F. C. Luft, and R. Kettritz
C5a Receptor Mediates Neutrophil Activation and ANCA-Induced Glomerulonephritis
J. Am. Soc. Nephrol.,
February 1, 2009;
20(2):
289 - 298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Flierl, D. Rittirsch, B. A. Nadeau, D. E. Day, F. S. Zetoune, J. V. Sarma, M. S. Huber-Lang, and P. A. Ward
Functions of the complement components C3 and C5 during sepsis
FASEB J,
October 1, 2008;
22(10):
3483 - 3490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Nitta, T. Imamura, Y. Wada, A. Irie, H. Kobayashi, K. Okamoto, and H. Baba
Production of C5a by ASP, a Serine Protease Released from Aeromonas sobria
J. Immunol.,
September 1, 2008;
181(5):
3602 - 3608.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Saethre, M. K. J. Schneider, J. D. Lambris, P. Magotti, G. Haraldsen, J. D. Seebach, and T. E. Mollnes
Cytokine Secretion Depends on Gal{alpha}(1,3)Gal Expression in a Pig-to-Human Whole Blood Model
J. Immunol.,
May 1, 2008;
180(9):
6346 - 6353.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Salvesen, M. Fung, O. D. Saugstad, and T. E. Mollnes
Role of Complement and CD14 in Meconium-Induced Cytokine Formation
Pediatrics,
March 1, 2008;
121(3):
e496 - e505.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-Y. Wang, E. Racila, R. P. Taylor, and G. J. Weiner
NK-cell activation and antibody-dependent cellular cytotoxicity induced by rituximab-coated target cells is inhibited by the C3b component of complement
Blood,
February 1, 2008;
111(3):
1456 - 1463.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. W. Pawluczkowycz, M. A. Lindorfer, J. N. Waitumbi, and R. P. Taylor
Hematin Promotes Complement Alternative Pathway-Mediated Deposition of C3 Activation Fragments on Human Erythrocytes: Potential Implications for the Pathogenesis of Anemia in Malaria
J. Immunol.,
October 15, 2007;
179(8):
5543 - 5552.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Jongerius, J. Kohl, M. K. Pandey, M. Ruyken, K. P.M. van Kessel, J. A.G. van Strijp, and S. H.M. Rooijakkers
Staphylococcal complement evasion by various convertase-blocking molecules
J. Exp. Med.,
October 1, 2007;
204(10):
2461 - 2471.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Lattin, D. A. Zidar, K. Schroder, S. Kellie, D. A. Hume, and M. J. Sweet
G-protein-coupled receptor expression, function, and signaling in macrophages
J. Leukoc. Biol.,
July 1, 2007;
82(1):
16 - 32.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O.-L. Brekke, D. Christiansen, H. Fure, M. Fung, and T. E. Mollnes
The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood
J. Leukoc. Biol.,
June 1, 2007;
81(6):
1404 - 1413.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. N. Ekdahl, D. Norberg, A. A. Bengtsson, G. Sturfelt, U. R. Nilsson, and B. Nilsson
Use of Serum or Buffer-Changed EDTA-Plasma in a Rapid, Inexpensive, and Easy-To-Perform Hemolytic Complement Assay for Differential Diagnosis of Systemic Lupus Erythematosus and Monitoring of Patients with the Disease
Clin. Vaccine Immunol.,
May 1, 2007;
14(5):
549 - 555.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Wrann, N. A. Tabriz, T. Barkhausen, A. Klos, M. van Griensven, H. C. Pape, D. O. Kendoff, R. Guo, P. A. Ward, C. Krettek, et al.
The Phosphatidylinositol 3-Kinase Signaling Pathway Exerts Protective Effects during Sepsis by Controlling C5a-Mediated Activation of Innate Immune Functions
J. Immunol.,
May 1, 2007;
178(9):
5940 - 5948.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Di Simone, P.L. Meroni, M. D'Asta, F. Di Nicuolo, M.C. D'Alessio, and A. Caruso
Pathogenic role of anti-{beta}2-glycoprotein I antibodies on human placenta: functional effects related to implantation and roles of heparin
Hum. Reprod. Update,
March 1, 2007;
13(2):
189 - 196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. von Gunten, A. Schaub, M. Vogel, B. M. Stadler, S. Miescher, and H.-U. Simon
Immunologic and functional evidence for anti-Siglec-9 autoantibodies in intravenous immunoglobulin preparations
Blood,
December 15, 2006;
108(13):
4255 - 4259.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Daniel, G. Dai, C. R. Singh, D. R. Lindsey, A. K. Smith, S. Dhandayuthapani, R. L. Hunter Jr, and C. Jagannath
The Reduced Bactericidal Function of Complement C5-Deficient Murine Macrophages Is Associated with Defects in the Synthesis and Delivery of Reactive Oxygen Radicals to Mycobacterial Phagosomes
J. Immunol.,
October 1, 2006;
177(7):
4688 - 4698.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Shi, Y. Tohyama, T. Kadono, J. He, S. M. Shahjahan Miah, R. Hazama, C. Tanaka, K. Tohyama, and H. Yamamura
Protein-tyrosine kinase Syk is required for pathogen engulfment in complement-mediated phagocytosis
Blood,
June 1, 2006;
107(11):
4554 - 4562.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Fiane, T. Ueland, S. Simonsen, H. Scott, K. Endresen, L. Gullestad, O. R. Geiran, G. Haraldsen, L. Heggelund, A. K. Andreassen, et al.
Low mannose-binding lectin and increased complement activation correlate to allograft vasculopathy, ischaemia, and rejection after human heart transplantation
Eur. Heart J.,
August 2, 2005;
26(16):
1660 - 1665.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. G. Therien, R. Baelder, and J. Kohl
Agonist Activity of the Small Molecule C3aR Ligand SB 290157
J. Immunol.,
June 15, 2005;
174(12):
7479 - 7480.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Allendorf, J. Yan, G. D. Ross, R. D. Hansen, J. T. Baran, K. Subbarao, L. Wang, and B. Haribabu
C5a-Mediated Leukotriene B4-Amplified Neutrophil Chemotaxis Is Essential in Tumor Immunotherapy Facilitated by Anti-Tumor Monoclonal Antibody and {beta}-Glucan
J. Immunol.,
June 1, 2005;
174(11):
7050 - 7056.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. T. Lappegard, J. Riesenfeld, O.-L. Brekke, G. Bergseth, J. D. Lambris, and T. E. Mollnes
Differential Effect of Heparin Coating and Complement Inhibition on Artificial Surface-Induced Eicosanoid Production
Ann. Thorac. Surg.,
March 1, 2005;
79(3):
917 - 923.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. T. Lappegard, M. Fung, G. Bergseth, J. Riesenfeld, and T. E. Mollnes
Artificial surface-induced cytokine synthesis: effect of heparin coating and complement inhibition
Ann. Thorac. Surg.,
July 1, 2004;
78(1):
38 - 44.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Sprong, A.-S. W. Moller, A. Bjerre, E. Wedege, P. Kierulf, J. W. M. van der Meer, P. Brandtzaeg, M. van Deuren, and T. E. Mollnes
Complement Activation and Complement-Dependent Inflammation by Neisseria meningitidis Are Independent of Lipopolysaccharide
Infect. Immun.,
June 1, 2004;
72(6):
3344 - 3349.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Boshra, J. Li, R. Peters, J. Hansen, A. Matlapudi, and J. O. Sunyer
Cloning, Expression, Cellular Distribution, and Role in Chemotaxis of a C5a Receptor in Rainbow Trout: The First Identification of a C5a Receptor in a Nonmammalian Species
J. Immunol.,
April 1, 2004;
172(7):
4381 - 4390.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Lin, D. Spencer, D. A. Hatala, A. D. Levine, and M. E. Medof
Decay-Accelerating Factor Deficiency Increases Susceptibility to Dextran Sulfate Sodium-Induced Colitis: Role for Complement in Inflammatory Bowel Disease
J. Immunol.,
March 15, 2004;
172(6):
3836 - 3841.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Shankar-Sinha, G. A. Valencia, B. K. Janes, J. K. Rosenberg, C. Whitfield, R. A. Bender, T. J. Standiford, and J. G. Younger
The Klebsiella pneumoniae O Antigen Contributes to Bacteremia and Lethality during Murine Pneumonia
Infect. Immun.,
March 1, 2004;
72(3):
1423 - 1430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. T. Lappegard, M. Fung, G. Bergseth, J. Riesenfeld, J. D. Lambris, V. Videm, and T. E. Mollnes
Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation
Ann. Thorac. Surg.,
March 1, 2004;
77(3):
932 - 941.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Woodruff, T. V. Arumugam, I. A. Shiels, R. C. Reid, D. P. Fairlie, and S. M. Taylor
A Potent Human C5a Receptor Antagonist Protects against Disease Pathology in a Rat Model of Inflammatory Bowel Disease
J. Immunol.,
November 15, 2003;
171(10):
5514 - 5520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Sprong, P. Brandtzaeg, M. Fung, A. M. Pharo, E. A. Hoiby, T. E. Michaelsen, A. Aase, J. W. M. van der Meer, M. van Deuren, and T. E. Mollnes
Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis
Blood,
November 15, 2003;
102(10):
3702 - 3710.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kirschfink and T. E. Mollnes
Modern Complement Analysis
Clin. Vaccine Immunol.,
November 1, 2003;
10(6):
982 - 989.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Fiane, V. Videm, P. S. Lingaas, L. Heggelund, E. W. Nielsen, O. R. Geiran, M. Fung, and T. E. Mollnes
Mechanism of Complement Activation and Its Role in the Inflammatory Response After Thoracoabdominal Aortic Aneurysm Repair
Circulation,
August 19, 2003;
108(7):
849 - 856.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|